CIDeRplusGeneral Information:
| Id: | 3,792 (click here to show other Interactions for entry) |
| Diseases: |
Alzheimer disease
- [OMIM]
|
| Mammalia | |
| review | |
| Reference: | Srikanth V et al.(2011) Advanced glycation endproducts and their receptor RAGE in Alzheimers disease Neurobiol. Aging 32: 763-777 [PMID: 19464758] |
Interaction Information:
| Comment | Although many epidemiological studies suggest that there is a connection between antioxidants and a reduced risk of AD, only a few trials with single antioxidants including Vitamin E, estrogen, and alpha-lipoic acid have displayed some benefits for AD patients, suggesting that these drugs are only effective in very early stages of the disease. |
|
Formal Description Interaction-ID: 38232 |
drug/chemical compound decreases_activity of disease |